Literature DB >> 29695602

Quantifying the mechanical and histological properties of thrombus analog made from human blood for the creation of synthetic thrombus for thrombectomy device testing.

William Merritt1,2, Anne Marie Holter1,2, Sharna Beahm1,2, Connor Gonzalez1,2, Timothy A Becker1,2, Aaron Tabor2, Andrew F Ducruet3, Laura S Bonsmann1,2, Trevor R Cotter2, Sergey Frenklakh4.   

Abstract

BACKGROUND: Untreated ischemic stroke can lead to severe morbidity and death, and as such, there are numerous endovascular blood-clot removal (thrombectomy) devices approved for human use. Human thrombi types are highly variable and are typically classified in qualitative terms - 'soft/red,' 'hard/white,' or 'aged/calcified.' Quantifying human thrombus properties can accelerate the development of thrombus analogs for the study of thrombectomy outcomes, which are often inconsistent among treated patients.
METHODS: 'Soft'human thrombi were created from blood samples ex vivo (ie, human blood clotted in sample vials) and tested for mechanical properties using a hybrid rheometer material testing system. Synthetic thrombus materials were also mechanically tested and compared with the 'soft' human blood clots.
RESULTS: Mechanical testing quantified the shear modulus and dynamic (elastic) modulus of volunteer human thrombus samples. This data was used to formulate a synthetic blood clot made from a composite polymer hydrogel of polyacrylamide and alginate (PAAM-Alg). The PAAM-Alg interpenetrating network of covalently and ionically cross-linked polymers had tunable elastic and shear moduli properties and shape memory characteristics.
CONCLUSIONS: Due to its adjustable properties, PAAM-Alg can be modified to mimic various thrombi classifications. Future studies will include obtaining and quantitatively classifying patient thrombectomy samples and altering the PAAM-Alg to mimic the results for use with in vitro thrombectomy studies. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  device; stroke; thrombectomy

Mesh:

Year:  2018        PMID: 29695602      PMCID: PMC9188866          DOI: 10.1136/neurintsurg-2017-013675

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   8.572


  16 in total

Review 1.  An efficacy and safety comparison between different stentriever designs in acute ischaemic stroke: a systematic review and meta-analysis.

Authors:  R Grech; R Pullicino; J Thornton; J Downer
Journal:  Clin Radiol       Date:  2015-11-17       Impact factor: 2.350

2.  Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke.

Authors:  Victor J Marder; Dennis J Chute; Sidney Starkman; Anna M Abolian; Chelsea Kidwell; David Liebeskind; Bruce Ovbiagele; Fernando Vinuela; Gary Duckwiler; Reza Jahan; Paul M Vespa; Scott Selco; Venkatakrishna Rajajee; Doojin Kim; Nerses Sanossian; Jeffrey L Saver
Journal:  Stroke       Date:  2006-06-22       Impact factor: 7.914

Review 3.  Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review.

Authors:  Waleed Brinjikji; Sharon Duffy; Anthony Burrows; Werner Hacke; David Liebeskind; Charles B L M Majoie; Diederik W J Dippel; Adnan H Siddiqui; Pooja Khatri; Blaise Baxter; Raul Nogeuira; Matt Gounis; Tudor Jovin; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2016-05-10       Impact factor: 5.836

4.  Gelling process differences in reverse emulsion, in situ gelling polymeric materials for intracranial aneurysm embolization, formulated with injectable contrast agents.

Authors:  Celeste M Riley; Ryan McLemore; Mark C Preul; Brent L Vernon
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-10-21       Impact factor: 3.368

5.  In vitro delivery, cytotoxicity, swelling, and degradation behavior of a liquid-to-solid gelling polymer system for cerebral aneurysm embolization.

Authors:  Celeste R Brennecka; Mark C Preul; Brent L Vernon
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2012-04-19       Impact factor: 3.368

6.  CT and MRI early vessel signs reflect clot composition in acute stroke.

Authors:  David S Liebeskind; Nerses Sanossian; William H Yong; Sidney Starkman; Michael P Tsang; Antonio L Moya; David D Zheng; Anna M Abolian; Doojin Kim; Latisha K Ali; Samir H Shah; Amytis Towfighi; Bruce Ovbiagele; Chelsea S Kidwell; Satoshi Tateshima; Reza Jahan; Gary R Duckwiler; Fernando Viñuela; Noriko Salamon; J Pablo Villablanca; Harry V Vinters; Victor J Marder; Jeffrey L Saver
Journal:  Stroke       Date:  2011-03-10       Impact factor: 7.914

7.  Endovascular treatment for acute ischemic stroke.

Authors:  Alfonso Ciccone; Luca Valvassori; Michele Nichelatti; Annalisa Sgoifo; Michela Ponzio; Roberto Sterzi; Edoardo Boccardi
Journal:  N Engl J Med       Date:  2013-02-06       Impact factor: 91.245

8.  Flow properties of liquid calcium alginate polymer injected through medical microcatheters for endovascular embolization.

Authors:  Timothy A Becker; Daryl R Kipke
Journal:  J Biomed Mater Res       Date:  2002-09-15

9.  Highly stretchable and tough hydrogels.

Authors:  Jeong-Yun Sun; Xuanhe Zhao; Widusha R K Illeperuma; Ovijit Chaudhuri; Kyu Hwan Oh; David J Mooney; Joost J Vlassak; Zhigang Suo
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

10.  Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation.

Authors:  Joris M Niesten; Irene C van der Schaaf; Lievay van Dam; Aryan Vink; Jan Albert Vos; Wouter J Schonewille; Peter C de Bruin; Willem P T M Mali; Birgitta K Velthuis
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more
  7 in total

Review 1.  Imaging Clot Characteristics in Stroke and its Possible Implication on Treatment.

Authors:  Ana Siri Luthman; Laurie Bouchez; Daniele Botta; Maria Isabel Vargas; Paolo Machi; Karl-Olof Lövblad
Journal:  Clin Neuroradiol       Date:  2019-10-10       Impact factor: 3.649

2.  Platelet-rich clots as identified by Martius Scarlet Blue staining are isodense on NCCT.

Authors:  Sean T Fitzgerald; Shunli Wang; Daying Dai; Andrew Douglas; Ramanathan Kadirvel; Matthew J Gounis; Juyu Chueh; Ajit S Puri; Kennith F Layton; Ike C Thacker; Ricardo A Hanel; Eric Sauvageau; Amin Aghaebrahim; Mohammed A Almekhlafi; Andrew M Demchuk; Raul G Nogueira; Vitor M Pereira; Peter Kvamme; Yasha Kayan; Josser E Delgado Almandoz; Albert J Yoo; David F Kallmes; Karen M Doyle; Waleed Brinjikji
Journal:  J Neurointerv Surg       Date:  2019-04-05       Impact factor: 5.836

3.  Standardized Fabrication Method of Human-Derived Emboli with Histologic and Mechanical Quantification for Stroke Research.

Authors:  Yang Liu; Adithya S Reddy; Joshua Cockrum; Miranda C Ajulufoh; Yihao Zheng; Albert J Shih; Aditya S Pandey; Luis E Savastano
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-08-07       Impact factor: 2.677

4.  Application of nondestructive mechanical characterization testing for creating in vitro vessel models with material properties similar to human neurovasculature.

Authors:  Nicholas G Norris; William C Merritt; Timothy A Becker
Journal:  J Biomed Mater Res A       Date:  2021-10-06       Impact factor: 4.854

5.  Endovascular thrombectomy 2020: open issues.

Authors:  Peter Lanzer; Petr Widimsky; Diana A Gorog; Mikael Mazighi; David Liebeskind; Christophe Cognard
Journal:  Eur Heart J Suppl       Date:  2020-12-06       Impact factor: 1.803

Review 6.  A Review of the Advancements in the in-vitro Modelling of Acute Ischemic Stroke and Its Treatment.

Authors:  Sarah Johnson; Anushree Dwivedi; Mahmood Mirza; Ray McCarthy; Michael Gilvarry
Journal:  Front Med Technol       Date:  2022-06-08

7.  Novel synthetic clot analogs for in-vitro stroke modelling.

Authors:  Helena Guerreiro; Nadine Wortmann; Thomas Andersek; Tuan N Ngo; Andreas M Frölich; Dieter Krause; Jens Fiehler; Anna A Kyselyova; Fabian Flottmann
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.